Guardant Health Inc. (GH)
NASDAQ
167.47
+1.91 (+1.15%)
Closed
Oct 9, 2026
Day's Range
166.03170.81
52 wk Range
61.00191.05
Financial Statements - GH - Guardant Health Inc.
Revenue
982.02M▲ 32.9%
Net Income
-416.27M▲ 4.6%Net Margin -42.4%
EBITDA
-373.90M▲ 4.2%
Free Cash Flow
-233.06M▲ 15.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 982.02M | 739.01M | 563.94M | 449.53M | 373.65M | 286.73M |
| Cost of Goods | 349M | 289.79M | 227.05M | 156.32M | 122.91M | 92.53M |
| Gross Profit | 633.01M | 449.21M | 336.89M | 293.21M | 250.74M | 194.19M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -437.24M | -443.59M | -564.72M | -544.37M | -411M | -254.95M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -10.49M | -42.60M | 53.17M | -112.56M | 25.17M | 3.64M |
| Pre Tax Income | -417.54M | -435.08M | -478.76M | -653.44M | -384.47M | -245.90M |
| Income Tax | -1.26M | 1.28M | 685K | 1.13M | 300K | 379K |
| Net Income | -416.27M | -436.37M | -479.44M | -654.58M | -384.77M | -246.28M |
| EPS Basic | -3.32 | -3.56 | -4.28 | -6.41 | -4 | -2.6 |
| EPS Diluted | -3.32 | -3.56 | -4.28 | -6.41 | -4 | -2.6 |
| Basic Shares Outstanding | 125.37M | 122.74M | 111.98M | 102.17M | 101.31M | 97.50M |
| Diluted Shares Outstanding | 125.37M | 122.74M | 111.98M | 102.17M | 101.31M | 97.50M |
| Ebit | -413.64M | -432.50M | -476.18M | -650.87M | -381.89M | -241.13M |
| Ebitda | -373.90M | -390.12M | -433.30M | -614.91M | -359.62M | -225.07M |
| Net Income Continuous Operations | -416.27M | -436.37M | -479.44M | -654.58M | -384.77M | -246.28M |
| Minority Interests | - | - | 0 | 0 | -20.90M | -7.50M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
